Utility of 99mTc-Sestamibi Heart/Liver Uptake Ratio in Screening Nonalcoholic Fatty Liver Disease During Myocardial Perfusion Imaging-Reference-Cited by-同舟云学术

Utility of 99mTc-Sestamibi Heart/Liver Uptake Ratio in Screening Nonalcoholic Fatty Liver Disease During Myocardial Perfusion Imaging

Published:2022-12-20 Issue: Volume: Page:
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Norouzi Ghazal¹²^ORCID,Nikdel Sara¹,Pirayesh Elahe¹²,Salimi Yazdan³,Amoui Mahasti¹²,Haghighatkhah Hamidreza²⁴,Ghodsi Rad Mohammad Ali¹²,Javanijouni Elmira⁵,Khoshbakht Sepideh¹²^ORCID

Affiliation:

1. Department of Nuclear Medicine, Shohada-e Tajrish Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

2. Clinical Research Development Unit, Shohada-e Tajrish Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

3. Biomedical Engineering and Medical Physics Department, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

4. Department of Diagnostic Imaging, Shohada-e Tajrish Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

5. School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/cbr.2022.0062

Reference23 articles.

1. Mechanisms of NAFLD development and therapeutic strategies

2. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

3. Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease

4. Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities

5. Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts